Abstract
The area of gene expression reagents is one of the newest and most important
sectors of pharmaceutical and bioscience research and development. The term
gene expression reagents refers to chemicals that are used in gene expression
experiments that are performed to determine whether a particular gene is
expressed-i.e., present-and in some cases at what levels, in a biological
sample. The purpose of this TriMark Publications report is to describe the
specific segments of the global gene expression reagents market. Within this
area, the study covers those segments that are highly active in terms of
innovation and growth. Specifically, this review examines the markets for gene
expression reagents and small lab equipment all the way up to highly automated
platforms. Emphasis is on those companies that are actively developing and
marketing gene expression reagents for genomics research in the academic
sector and the pharmaceutical, bioscience industry. This study concentrates on
the laboratory reagent market segment and the companion gene expression
reagents sector in the U.S. and around the world that use materials for
genetic research. Particular attention is paid to those areas of the gene
expression reagents sector that are showing the greatest growth or the most
innovation.
The report attempts to answer the following questions:
- What companies are the key players?
- What is the market for gene express reagents?
- What are the opportunities in gene expression reagents markets?
- What are the developing trends?
- Where are the new market growth areas?
- What are the most favored technology platforms?
- Where are the gene expression reagent technologies taking researchers?
- How are gene expression reagent technologies blending with more
established laboratory procedures?
- What are the business trends in the industry?
The study surveys some of the leading companies known to be marketing,
manufacturing or developing products for the gene expression reagents market
for those sectors covered here. Each company is discussed in depth with a
section on the history of the company, the product line, business and
marketing analysis, and a subjective commentary of the position of the company
in its market.
The benefits of this report are:
- In-depth analysis of the major sectors of the gene expression reagent
sectors, their size, growth rates and major drivers.
- Presentation of some of the emerging technology platforms, elucidating the
potential areas that could gain traction in this market.
- Analysis of the partnerships and alliances the various key sector players
have forged, as well as describing financings of these market participants,
giving insight into potential market collaborations.
- Examination of new technology platforms that seek to dominate this new
market, and to identify lead positions and potential future growth areas.
- An overview of the current state of gene expression assays used in drug
development and the numerous opportunities that exist to increase the quality
of genetic sequences evaluated.
- A profile of the gene expression customer and an analysis of factors
influencing the adoption of specific gene exploration technology.
- A five-year projection of spending on new equipment and reagents.
- Impact of commercial gene reagents on genetic R&D.